Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000972290 | SCV001119993 | likely benign | not provided | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002505476 | SCV002803648 | likely benign | Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome | 2021-08-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002548366 | SCV003754797 | uncertain significance | Inborn genetic diseases | 2021-08-13 | criteria provided, single submitter | clinical testing | The c.877T>G (p.F293V) alteration is located in exon 7 (coding exon 7) of the SCYL1 gene. This alteration results from a T to G substitution at nucleotide position 877, causing the phenylalanine (F) at amino acid position 293 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV000972290 | SCV005211312 | likely benign | not provided | criteria provided, single submitter | not provided |